MACSF
2 rounds tracked since 29 September 2025.
- Rounds
- 2
- Led
- 0
- Capital in these rounds
- $40.6M
Sectors
Countries
Rounds
- Enodia TherapeuticsDevelops small molecules that degrade disease proteins at synthesis via SEC61 translocon $24.2MSeed · 8 Jan
- RDSConnected patch for remote patient monitoring (MultiSense) $16.4MSeries A · 29 Sept
No round matches these filters.